Study suggests convalescent plasma may be safe COVID-19 treatment
4.7 (199) · € 25.00 · En Stock
In a small study of 14 infants and children, convalescent plasma from patients who recovered from COVID-19 infection provided expected antibody levels and raised no safety concerns
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Convalescent Plasma Is Safe to Treat Covid-19, National Study Shows - WSJ
Viruses, Free Full-Text
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Convalescent plasma therapy ineffective in treating severe COVID-19, study finds
Convalescent plasma to deliver therapeutic antibodies against COVID-19: Trends in Molecular Medicine
Convalescent plasma is safe to treat COVID-19: nationwide study
COVID treatment warrants fresh look
Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes
Convalescent plasma appears safe as COVID-19 treatment, study shows
Study Says Blood Plasma Reduces Risk of Severe Covid-19 if Given Early - The New York Times
Convalescent plasma to deliver therapeutic antibodies against COVID-19: Trends in Molecular Medicine
Convalescent plasma to treat COVID-19: clinical experience and efficacy
Blood transfusion services amidst the COVID-19 pandemic — JOGH
